Archive - January 2022
Moderna begins phase 2 trial of Omicron-specific booster
FDA Approves Vabysmo (faricimab-svoa) for the Treatment of Neovascular (Wet) Age-Related Macular Degeneration and Diabetic Macular Edema
FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments
Janssen’s Tremfya receives positive results for active psoriatic arthritis
Fast paced trial chasing down COVID-19 symtoms
Voxelotor for haemolytic anaemia treatment gains positive opinion
CORBEVAX, A New Patent-Free COVID-19 Vaccine, Could Be A Pandemic Game Changer Globally
FDA Approves Kimmtrak (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma